Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02179710 · ClinicalTrials.gov registry record
Cystic Fibrosis Treatment Adherence Cayston Proof-of-Concept Pilot Study
A clinical trial, sponsored by Landon Pediatric Foundation.
- Completed
- Registry status
- 18
- Enrollment target
NCT02179710: Completed study, sponsored by Landon Pediatric Foundation.
NCT02179710 is a clinical trial that has completed, run by Landon Pediatric Foundation. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02179710 has completed, sponsored by Landon Pediatric Foundation.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
Real-world adherence to inhaled and oral therapies for cystic fibrosis (CF) patients remains discouragingly low, ranging between 31-53% for inhaled antibiotics and 41-72% for hypertonic saline. Programs to enhance adherence, including comprehensive behavioral interventions with adolescents, have met with mixed success. Advances in therapy, treatment delivery systems, and data capture technology offer the potential for enhancing adherence by providing immediate and more frequent feedback to the patient regarding his or her fidelity to the prescribed treatment regimen. We propose to conduct a proof-of-concept study to evaluate a systematic approach to linking treatment and feedback components to enhance adherence.
Primary Outcome
Doses of medication as recorded by bluetooth device
Interventions
- BEHAVIORAL Adherence dashboard motivational interviewing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2015-03 |
| Est. Completion | 2016-09 |
What the finished NCT02179710 record still lists
NCT02179710 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Adherence dashboard motivational interviewing is the first listed.
NCT02179710 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02179710 about?
NCT02179710 is a clinical study titled "Cystic Fibrosis Treatment Adherence Cayston Proof-of-Concept Pilot Study". Real-world adherence to inhaled and oral therapies for cystic fibrosis (CF) patients remains discouragingly low, ranging between 31-53% for inhaled antibiotics and 41-72% for hypertonic saline. Programs to enhance adherence, including comprehensive behavioral interventions with adolescents, have met...
What is the current status of trial NCT02179710?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2015-03. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02179710?
The interventions under investigation include: Adherence dashboard motivational interviewing (BEHAVIORAL).
Who is sponsoring clinical trial NCT02179710?
This trial is sponsored by Landon Pediatric Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia